nach oben

Erschienen in:

01.08.2008 | Original Paper

Sporadic amyotrophic lateral sclerosis: two pathological patterns shown by analysis of distribution of TDP-43-immunoreactive neuronal and glial cytoplasmic inclusions

verfasst von: Yasushi Nishihira, Chun-Feng Tan, Osamu Onodera, Yasuko Toyoshima, Mitsunori Yamada, Takashi Morita, Masatoyo Nishizawa, Akiyoshi Kakita, Hitoshi Takahashi

Erschienen in: Acta Neuropathologica | Ausgabe 2/2008

Einloggen, um Zugang zu erhalten

Abstract

A nuclear protein, 43-kDa TAR DNA-binding protein (TDP-43), was recently identified as a component of the ubiquitinated inclusions (UIs) in frontotemporal lobar degeneration (FTLD-U) and sporadic amyotrophic lateral sclerosis (SALS). In the present study using immunohistochemistry, we examined various regions of the nervous system in a series of 35 SALS cases using a polyclonal antibody against TDP-43. Seven of the 35 cases had disease durations of more than 10 years with artificial respiratory support (ARS; duration: 69–156 months). In all cases, TDP-43-immunoreactive (ir) neuronal and glial cytoplasmic inclusions (NCIs and GCIs) were found together in many regions, including the histologically affected lower motor neuron nuclei. Cluster analysis of the distribution pattern of TDP-43-ir NCIs for cases without ARS (n = 28) identified two types (type 1, n = 16; type 2, n = 12). Type 2 was distinguished from type 1 by the presence of TDP-43-ir NCIs in the frontotemporal cortex, hippocampal formation, neostriatum and substantia nigra, and was significantly associated with dementia. Eleven of the 28 cases showed UIs in the hippocampal dentate granule cells, all of which had type-2 distribution pattern. Cases with ARS (n = 7) were also classified into the same types (type 1, n = 5; type 2, n = 2). Cases having type-1 distribution pattern (n = 21) showed no evident neuronal loss in most of the non-motor neuron nuclei where TDP-43-ir NCIs were present, whereas cases having type-2 distribution pattern (n = 14) often showed evident neuronal loss in the frontotemporal cortices, amygdaloid nuclei and substantia nigra. These findings indicate that SALS is a multisystem degenerative disease widely affecting both neurons and glial cells with a heterogeneous pattern of TDP-43-ir NCI distribution (SALS showing type-2 distribution pattern being closely linked to FTLD-U), and that long-term survival supported by a respirator has no apparent influence on the TDP-43 neuronal distribution pattern.

Al-Sarraj S, Maekawa S, Kibble M, Everall I, Leigh N (2002) Ubiquitin-only intraneuronal inclusion in the substantia nigra is a characteristic feature of motor neuron disease with dementia. Neuropathol Appl Neurobiol 28:120–128PubMedCrossRef

Arai A, Hasegawa M, Akiyama H, Ikeda K, Nonaka T, Mori H, Mann D, Tsuchiya K, Yoshida M, Hashizume Y, Oda T (2006) TDP-43 is a component of ubiquitin-positive inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Commun 351:602–611PubMedCrossRef

Brandmeir NJ, Geser F, Kwong LK, Zimmerman E, Qian J, Lee VM-Y, Trojanowski JQ (2008) Severe subcortical TDP-43 pathology in sporadic frontotemporal lobar degeneration with motor neuron disease. Acta Neuropathol 115:123–131PubMedCrossRef

Cairns NJ, Bigio EH, Mackenzie IR, Neumann M, Lee VM-Y, Hatanpaa KJ, White III CL, Schneider JA, Grinberg LT, Halliday G, Duyckaerts C, Lowe JM, Holm IE, Tolnay M, Okamoto K, Yokoo H, Murayama S, Woulfe J, Munoz DG, Dickson DW, Ince P, Trojanowski JQ, Mann DM (2007) Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration. Acta Neuropathol 114:5–22PubMedCrossRef

Davidson Y, Kelley T, Mackenzie IR, Pickering-Brown S, Plessis DD, Neary D, Snowden JS, Mann DM (2007) Ubiquitinated pathological lesions in frontotemporal lobar degeneration contain the TAR DNA-binding protein, TDP-43. Acta Neuropathol 113:521–533PubMedCrossRef

Dickson DW, Josephs KA, Amador-Ortiz (2007) TDP-43 in differential diagnosis of motor neuron disorders. Acta Neuropathol 114:39–47CrossRef

Gitcho MA, Baloh RH, Chakraverty S, Mayo K, Norton JB, Levitch D, Hatanpaa KJ, White CL 3rd, Bigio EH, Caselli R, Baker M, Al-Lozi MT, Morris JC, Pestronk A, Rademakers R, Goate AM, Cairns NJ (2008) TDP-43 A315T mutation in familial motor neuron disease. Ann Neurol 63:535–538PubMedCrossRef

Gros-Louis F, Gaspar C, Rouleau GA (2006) Genetics of familial and sporadic amyotrophic lateral sclerosis. Biochim Biophys Acta 1762:956–972PubMed

Hayashi H, Kato S (1989) Total manifestation of amyotrophic lateral sclerosis. ALS in the totally locked-in state. J Neurol Sci 93:19–35PubMedCrossRef

10.

Hudson AJ (1981) Amyotrophic lateral sclerosis and its association with dementia, parkinsonism and other neurological disorders: a review. Brain 104:217–247PubMedCrossRef

11.

Ince PG, Lowe J, Shaw PJ (1998) Amyotrophic lateral sclerosis: current issues in classification, pathogenesis and molecular pathology. Neuropathol Appl Neurobiol 24:104–117PubMedCrossRef

12.

Kabashi E, Valdmanis PN, Dion P, Spiegelman D, McConkey BJ, Velde CV, Bouchard JP, Lacomblez L, Pochigaeva K, Salachas F, Pradat PF, Camu W, Meininger V, Dupre N, Rouleau GA (2008) TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. Nat Genet 40:572–574PubMedCrossRef

13.

Kato S, Hayashi H, Oda M, Kawata A, Shimizu T, Hayashi M, Dugaya K, Arai N (1996) Neuropathology in sporadic ALS patients on respirators. In: Nakano I, Hirano A (eds) Amyotrophic lateral sclerosis: progress and perspectives in basic research and clinical application. Elsevier, Amsterdam, pp 66–77

14.

Kato S, Oda M, Hayashi H, Kawata A, Shimizu T (1994) Participation of the limbic system and its associated area in the dementia of amyotrophic lateral sclerosis. J Neurol Sci 126:62–69PubMedCrossRef

15.

Kawashima T, Doh-ura K, Kikuchi H, Iwaki T (2001) Cognitive dysfunction in patients with amyotrophic lateral sclerosis is associated with spherical or crescent-shaped ubiquitinated intraneuronal inclusions in the parahippocampal gyrus and amygdala, but not in the neostriatum. Acta Neuropathol 102:467–472PubMed

16.

Kawashima T, Kikuchi H, Takita M, Doh-ura K, Ogomori K, Oda M, Iwaki T (1998) Skein-like inclusions in the neostriatum from a case of amyotrophic lateral sclerosis with dementia. Acta Neuropathol 96:541–545PubMedCrossRef

17.

Kim KW, Lee DY, Jhoo JH, Youn JC, Suh YJ, Jun YH, Seo EH, Woo JI (2005) Diagnostic accuracy of minimental status examination and revised Hasegawa dementia scale for Alzheimer’s disease. Dement Geriatr Cogn Disord 19:324–330PubMedCrossRef

18.

Kwong LK, Neumann M, Sampathu DM, Lee V M-Y, Trojanowski JQ (2007) TDP-43 proteinopathy: the neuropathology underlying major forms of sporadic and familial frontotemporal degeneration and motor neuron disease. Acta Neuropathol 114:63–70PubMedCrossRef

19.

Leigh PN, Anderton BH, Dodson A, Gallo JM, Swash M, Power DM (1988) Ubiquitin deposits in anterior horn cells in motor neuron disease. Neurosci Lett 93:197–203PubMedCrossRef

20.

Leigh PN, Withwell H, Garofalo O, Buller J, Swash M, Martin JE, Gallo JM, Weller RO, Anderton BH (1991) Ubiquitin-immunoreactive intraneuronal inclusions in amyotrophic lateral sclerosis. Morphology, distribution, and specificity. Brain 114:775–788PubMedCrossRef

21.

Lowe J (1994) New pathological findings in amyotrophic lateral sclerosis. J Neurol Sci 124(Suppl):38–51PubMedCrossRef

22.

Lowe J, Lennox G, Jefferson D, Morrell K, McQuire D, Gray T, Landon M, Doherty FJ, Mayer RJ (1988) A filamentous inclusion body within anterior horn neurons in motor neuron disease defined by immunocytochemical localization of ubiquitin. Neurosci Lett 94:203–210PubMedCrossRef

23.

Mackenzie IR, Bigio EH, Ince PG, Geser F, Neumann M, Cairns NJ, Kwong L, Forman MS, Ravits J, Stewart H, Eisen A, McClusky L, Kretzschmar HA, Monoranu CM, Highley JR, Kirby J, Siddique T, Shaw PJ, Lee VM-Y, Trojanowski JQ (2007) Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1mutations. Ann Neurol 61:427–434PubMedCrossRef

24.

Mackenzie IR, Feldman H (2004) Extrapyramidal features in patients with motor neuron disease and dementia; a clinicopathological correlative study. Acta Neuropathol 107:336–340PubMedCrossRef

25.

Mackenzie IR, Feldman HH (2005) Ubiquitin immunohistochemistry suggest classic motor neuron disease, motor neuron disease with dementia, and frontotemporal dementia of motor neuron disease type represent a clinicopathologic spectrum. J Neuropathol Exp Neurol 64:730–739PubMedCrossRef

26.

McKhann GM, Albert MS, Grossman M, Miller B, Dickson D, Trojanowski JQ Work Group on Frontotemporal Dementia, Pick’s disease (2001) Clinical and pathological diagnosis of frontotemporal dementia: report of the work group of frontotemporal demetia and Pick’s disease. Arch Neurol 58:1803–1809PubMedCrossRef

27.

Mitsuyama Y (1984) Presenile dementia with motor neuron disease in Japan: clinicopathological review of 26 cases. J Neurol Neurosurg Psychiatry 47:953–959PubMedCrossRef

28.

Mizutani T, Sakamaki S, Tsuchiya N, Namei S, Kohzu H, Horiuchi R, Ida M, Shiozawa R, Takasu T (1992) Amyotrophic lateral sclerosis with ophthalmoplegia and multisystem degeneration in patients on long-term use of respitators. Acta Neuropathol 84:372–377PubMedCrossRef

29.

Mulder DW, Kurland LT, Offord KP, Beard CM (1986) Familial adult motor neuron disease: amyotrophic lateral sclerosis. Neurology 36:511–517PubMed

30.

Nakano I (1993) Temporal lobe lesions in amyotrophic lateral sclerosis with or without dementia: a neuropathological study. Neuropathology 13:215–227CrossRef

31.

Nakano I (2000) Frontotemporal dementia with motor neuron disease (amyotrophic lateral sclerosis with dementia). Neuropathology 20:68–75PubMedCrossRef

32.

Neumann M, Kwong LK, Truax AC, Vanmassenhove B, Kretzschmar HA, Van Deerlin VM, Clark CM, Grossman M, Miller BL, Trojanowski JQ, Lee VM-Y (2007) TDP-43-positive white matter pathology in frontotemporal lobar degeneration with ubiquitin-positive inclusions. J Neuropathol Exp Neurol 66:177–183PubMedCrossRef

33.

Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, Bruce J, Schuck T, Grossman M, Clark CM, McCluskey LF, Miller BK, Masliah E, Mackenzie IR, Feldman H, Feiden W, Kretzschmar HA, Trojanowski JQ, Lee VM-Y (2006) Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314:130–133PubMedCrossRef

34.

Okamoto K, Hirai S, Yamazaki T, Sun XY, Nakazato Y (1991) New ubiquitin-positive intraneuronal inclusions in the extra-motor cortices in patients with amyotrophic lateral sclerosis. Neurosci Lett 129:233–236PubMedCrossRef

35.

Okamoto K, Mizuno Y, Fujita Y (2008) Bunina bodies in amyotrophic lateral sclerosis. Neuropathology 28:109–115PubMedCrossRef

36.

Okamoto K, Murakami N, Kusaka H, Yoshida M, Hashizume Y, Nakazato Y, Matsubara E, Hirai S (1992) Ubiquitin-positive intraneuronal inclusions in the extramotor cortices of presenile dementia patients with motor neuron disease. J Neurol 239:426–430PubMedCrossRef

37.

Piao Y-S, Wakabayashi K, Kakita A, Yamada M, Hayashi S, Morita T, Ikuta F, Oyanagi K, Takahashi H (2003) Neuropathology with clinical correlations of sporadic amyotrophic lateral sclerosis: 102 autopsy cases examined between 1962 and 2000. Brain Pathol 13:10–22PubMed

38.

Rossi GL, Luginbühl H, Probst D (1970) A method for ultrastructural study of lesions found in conventional histological sections. Virchows Arch [A] 350:216–224

39.

Sreedharan J, Blair IP, Tripathi VB, Hu X, Vance C, Rogelj B, Ackerley S, Durnall JC, Williams KL, Buratti E, Baralle F, de Belleroche J, Mitchell JD, Leigh PN, Al-Chalabi A, Miller CC, Nicholson G, Shaw CE (2008) TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science 319:1668–1672PubMedCrossRef

40.

Su M, Yoshida Y, Ishiguro H, Hirota K (1999) Nigral degeneration in a case of amyotrophic lateral sclerosis: evidence of Lewy body-like and skein-like inclusions in the pigmented neurons. Clin Neuropathol 18:293–300PubMed

41.

Takahashi H, Oyanagi K, Ikuta F (1993) The intermediolateral nucleus in sporadic amyotrophic lateral sclerosis. Acta Neuropathol 86:190–192PubMedCrossRef

42.

Takahashi H, Oyanagi K, Ohama E, Ikuta F (1992) Clarke’s column in sporadic amyotrophic lateral sclerosis. Acta Neuropathol 84:465–470PubMedCrossRef

43.

Tan C-F, Eguchi H, Tagawa A, Onodera O, Iwasaki T, Tsujino A, Nishizawa M, Kakita A, Takahashi H (2007) TDP-43 immunoreactivity in neuronal inclusions in familial amyotrophic lateral sclerosis with or without SOD1 gene mutation. Acta Neuropathol 113:535–542PubMedCrossRef

44.

Van Deerlin VM, Leverenz JB, Bekris LM, Bird TD, Yuan W, Elman LB, Clay D, Wood EM, Chen-Plotkin AS, Martinez-Lage M, Steinbart E, McCluskey L, Grossman M, Neumann M, Wu IL, Yang WS, Kalb R, Galasko DR, Montine TJ, Trojanowski JQ, Lee VM, Schellenberg GD, Yu CE (2008) TARDBP mutation in amyotrophic lateral sclerosis with TDP-43 neuropathology: a genetic and histopathological analysis. Lancet Neurol 7:409–416PubMedCrossRef

45.

Wakabayashi K, Piao Y-S, Hayashi S, Kakita A, Yamada M, Takahashi H (2001) Ubiquitinated neuronal inclusions in the neostriatum in patients with amyotrophic lateral sclerosis with and without dementia—a study of 60 patients 31 to 87 years of age. Clin Neuropathol 20:47–52PubMed

46.

Wightman G, Anderson VER, Martin J, Swash M, Anderton BH, Neary D, Mann D, Luthert P, Leigh PN (1992) Hippocampal and neocortical ubiquitin-immunoreactive inclusions in amyotrophic lateral sclerosis with dementia. Neurosci Lett 139:269–274PubMedCrossRef

47.

Wilson CM, Grace GM, Munoz DG, He BP, Strong MJ (2001) Cognitive impairment in sporadic ALS. A pathologic continuum underlying a multisystem disorder. Neurology 57:651–657PubMed

48.

Yokoseki A, Shiga A, Tan C-F, Tagawa A, Kaneko H, Koyama A, Eguchi H, Tsujino A, Ikeuchi T, Kakita A, Okamototo K, Nishizawa M, Takahashi H, Onodera O (2008) TDP-43 mutation in familial amyotrophic lateral sclerosis. Ann Neurol 63:538–542PubMedCrossRef

49.

Yoshida M (2004) Amyotrophic lateral sclerosis with dementia: the clinicopathological spectrum. Neuropathology 24:87–102PubMedCrossRef

50.

Yoshida M, Murakami N, Hashizume Y, Itoh E, Takahashi A (1992) A clinicopathological study of two respirator-aided long-survival cases of amyotrophic lateral sclerosis (in Japanese with English abstract). Rinsho Shikeigaku 32:259–265

51.

Zhang H, Tan C-F, Mori F, Tanji K, Kakita A, Takahashi H, Wakabayashi K (2008) TDP-43-immunoreactive neuronal and glial inclusions in the neostriatum in amyotrophic lateral sclerosis with and without dementia. Acta Neuropathol 115:115–122PubMedCrossRef

Titel: Sporadic amyotrophic lateral sclerosis: two pathological patterns shown by analysis of distribution of TDP-43-immunoreactive neuronal and glial cytoplasmic inclusions
verfasst von: Yasushi Nishihira
Chun-Feng Tan
Osamu Onodera
Yasuko Toyoshima
Mitsunori Yamada
Takashi Morita
Masatoyo Nishizawa
Akiyoshi Kakita
Hitoshi Takahashi
Publikationsdatum: 01.08.2008
Verlag: Springer-Verlag
Erschienen in: Acta Neuropathologica / Ausgabe 2/2008
Print ISSN: 0001-6322
Elektronische ISSN: 1432-0533
DOI: https://doi.org/10.1007/s00401-008-0385-z

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2008

TDP-43 inclusions do not protect motor neurons from sporadic ALS

Maturation process of TDP-43-positive neuronal cytoplasmic inclusions in amyotrophic lateral sclerosis with and without dementia

TDP-43 protein in plasma may index TDP-43 brain pathology in Alzheimer’s disease and frontotemporal lobar degeneration

TAR DNA-binding protein-43 in amyotrophic lateral sclerosis, frontotemporal lobar degeneration, and Alzheimer disease

White matter lesions in the brain with frontotemporal lobar degeneration with motor neuron disease: TDP-43-immunopositive inclusions co-localize with p62, but not ubiquitin